A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of OBI-858 for the Treatment of Moderate-to-Severe Glabellar Lines. - Yen, Yu-Hsiu; Tsau, Tzu-Wen; Lee, Chih-Hung; Chen, Hsin-Han; Lin, Chih-Hung; Chen, Tim-Mo; Pu, Chi-Ming (Dermatology & Therapy, 2025)